Iboga root bark
This generally refers to root-bark material from Tabernanthe iboga. It is plant material, not a single purified compound. Natural variation, processing, identity, storage, and contamination can all affect what is actually present.
Ibogaine ingredient labels
Ingredient Breakdown
A neutral guide to the terms commonly used on ibogaine-related labels—and to what those terms can and cannot establish.
For adults assessing label language, the useful starting point is simple: a product name is not a verified composition, and a composition claim is not a safety claim.
Start with the noun
A label may name a plant, a mixture, a molecule, or a salt.
Those are not interchangeable categories. A label can sound precise while leaving essential questions unanswered: which material was tested, whether the result applies to the specific batch, what measurement method was used, and whether other compounds were present.
For broader context on how terminology, product claims, and uncertainty fit together, the main ibogaine label guide sets out the same evidence-first approach. The terms below are best read as descriptive language, not as proof of purity, quality, legality, or safety.
Iboga extract
This is a broad phrase for material obtained from iboga through extraction. By itself, it does not state the solvent, method, alkaloid profile, concentration, or whether a stated result is batch-specific.
Total alkaloid extract
This usually indicates a mixture of alkaloids extracted from iboga material. “Total” does not mean every compound is identified, nor does it establish the proportion of ibogaine or other alkaloids in that mixture.
Ibogaine hydrochloride
This names ibogaine in a hydrochloride salt form. It is more chemically specific than “extract,” but a name alone does not verify identity, concentration, contaminants, or whether the material matches the label.
Plant language and extract language
Root bark and extracts describe different levels of processing.
“Iboga root bark” ordinarily describes starting botanical material. A label that says “iboga extract” moves one step away from that starting material, but it still does not identify a standardized chemical composition. The scientific description of Tabernanthe iboga is useful background for distinguishing the plant from the substances that can be derived from it.
“Total alkaloid extract” often sounds more definite because it names a chemical family. In plain language, it generally means a preparation containing more than one alkaloid rather than a single isolated compound. It does not, on its own, explain which alkaloids are present, in what proportions, or how consistently one batch resembles another.
That distinction matters because a label can use terms such as “full spectrum,” “total,” or “standardized” without stating the standard, the laboratory method, or the specific batch. For questions that labels cannot answer by themselves, the certificate-reading framework focuses on what a document actually identifies and what it leaves unresolved.
Chemical names
Named forms can be more specific, but specificity is not verification.
Ibogaine is one named alkaloid associated with iboga. Ibogaine’s reference entry describes it as a psychoactive alkaloid, while the label terms “hydrochloride” and “freebase” describe different chemical forms of that compound.
- Ibogaine hydrochloride is ibogaine paired with hydrochloride as a salt. A salt form is not the same thing as plant material or a total alkaloid mixture.
- Freebase ibogaine generally refers to the non-salt form of ibogaine. The term identifies a chemical form, not an independently confirmed product identity.
- Noribogaine is a compound related to ibogaine and commonly discussed as a metabolite. A label naming it should still be read for what it specifically claims, rather than assumed to establish a complete chemical profile.
“Hydrochloride,” “freebase,” and “extract” are category words. They do not establish purity, contaminant status, or individual safety.
Federal health agencies describe ibogaine as an unapproved substance with potentially serious risks; the National Institute on Drug Abuse’s overview of psychedelics and dissociative drugs provides broader safety context. Label language should never be used to infer medical suitability or safety.
Analogues and ambiguity
“Synthetic analogue” is a broad label, not a single ingredient.
Synthetic analogues are compounds designed to be chemically related to another compound without necessarily being identical to it. On an ibogaine-related label, that phrase requires additional context: the exact chemical name, the claimed identity, the method used to support that identity, and whether the claim applies to the lot in question.
A related structure does not establish identical pharmacology, effects, safety profile, or legal status. The PubChem chemical database illustrates why exact compound identifiers matter: names alone can be incomplete, while structure and identifier information clarify what substance is being discussed.
Be especially cautious when a label blends technical language with undefined terms—such as “research grade,” “pharmaceutical,” “clinical,” “pure,” or “premium.” Those phrases may be marketing language unless the label explains their basis and connects them to verifiable batch information.
Reading limits
What a label cannot settle on its own.
Even a detailed ingredient panel has limits. A helpful label may support a more focused question, but it cannot replace independent testing, context, or risk awareness.
People comparing terminology used across marketplaces may encounter varying descriptions through resources such as ibogaine availability listings, but differing descriptions should not be treated as a quality ranking.
Does a percentage on a label establish purity?
No. A percentage may describe a claim, a selected analytical result, or an unclear basis of measurement. Without a batch-specific certificate and understandable testing context, it should not be treated as proof of purity.
Does a label establish safety?
No. Ingredient wording does not establish identity, dose, contaminants, individual suitability, interactions, or medical safety. For a wider view of label limits and risk-relevant questions, see testing and risk context.
What is the key difference between total alkaloid extract and ibogaine hydrochloride?
A total alkaloid extract describes a mixture of alkaloids from iboga material. Ibogaine hydrochloride describes a salt form of one named compound. The labels identify different kinds of material and should not be treated as interchangeable.
Why do similar terms appear across different settings?
Terms can be used by sellers, directories, and treatment-oriented sites with different levels of detail. For example, facility-oriented ibogaine information may use category labels that do not answer product-specific composition questions.
A measured conclusion
Read labels as claims that need context.
Terms such as root bark, extract, total alkaloids, hydrochloride, freebase, noribogaine, and synthetic analogue can help identify the kind of material being described. They do not, by themselves, prove identity, purity, safety, or appropriateness.
Specialized labels may also appear in discussions of ibogaine and PTSD treatment, military-focused ibogaine conversations, or Canadian ibogaine resources; the same caution applies across every setting.
Explore the resource approach